If the goal of President-elect Donald Trump's Department of Government Efficiency is to root out government waste and inefficiency, NCPA CEO Douglas Hoey wrote in a letter to DOGE's general counsel, it should focus on the big three PBMs that fleece taxpayers, patients, and pharmacies alike.
"PBMs' anticompetitive practices, opaque reimbursement models, and restrictive contract terms have created an environment in which they can use their overwhelming market power to steer patients away from their competitors to their own pharmacies and pay themselves higher prescription reimbursement rates," he wrote. "Shockingly, these health insurance PBMs received billions of dollars in bailout subsidies from the federal government to keep premiums stable in Medicare Part D."
To read the full press release, click here.
